Artwork for podcast Pathfinders in Biopharma
How PIPEs finally unblocked biotech’s funding flows
Episode 22 • 29th March 2024 • Pathfinders in Biopharma • RBC Capital Markets
00:00:00 00:17:36

Share Episode

Shownotes

The first quarter of 2024 has seen biotech’s funding drought broken, largely through private investment in public equity (PIPE) deals. In this episode of Pathfinders in Biopharma, three members of RBC’s biotech investment banking team look at the impact of PIPEs’ success on the sector and consider how long it can last – and why it has not been universally welcomed.

Follow

Links

Chapters

Video

More from YouTube